GUCY2D-Associated Leber Congenital Amaurosis: A Retrospective Natural History Study in Preparation for Trials of Novel Therapies.


Journal

American journal of ophthalmology
ISSN: 1879-1891
Titre abrégé: Am J Ophthalmol
Pays: United States
ID NLM: 0370500

Informations de publication

Date de publication:
02 2020
Historique:
received: 11 07 2019
revised: 21 10 2019
accepted: 23 10 2019
pubmed: 11 11 2019
medline: 2 5 2020
entrez: 10 11 2019
Statut: ppublish

Résumé

To describe the natural history of Leber congenital amaurosis (LCA) associated with GUCY2D variants (GUCY2D-LCA) in a cohort of children and adults, in preparation for trials of novel therapies. Retrospective case series. Participants: Patients with GUCY2D-LCA at a single referral center. Review of clinical notes, retinal imaging including fundus autofluorescence (FAF) and optical coherence tomography (OCT), electroretinography (ERG), and molecular genetic testing. Demographic data, symptoms at presentation, visual acuity, evidence of progression, OCT and FAF findings, ERG assessment, and molecular genetics. Twenty-one subjects with GUCY2D-LCA were included, with a mean follow-up ± standard deviation (SD) of 10 ± 11.85 years. Marked reduction in visual acuity (VA) and nystagmus was documented in all patients within the first 3 years of life. Fifty-seven percent (n = 12) exhibited photophobia and 38% (n = 8) had nyctalopia. VA was worse than hand motion in 71% of the patients (n = 15). Longitudinal assessment of VA showed stability in all patients, except 1 patient who experienced deterioration over a follow-up of 44 years. Hyperopia was reported in 13 of the 17 subjects (71%) with available refraction data. Eighteen subjects had either normal fundus appearance (n = 14) or a blond fundus (n = 3), while only 4 of the eldest subjects had mild retinal pigment epithelium (RPE) atrophy (mean, 49 years; range 40-54 years). OCT data were available for 11 subjects and 4 different grades of ellipsoid zone (EZ) integrity were identified: (1) continuous/intact EZ (n = 6), (2) focally disrupted EZ (n = 2), (3) focally disrupted with RPE changes (n = 2), and (4) diffuse EZ disruption with RPE changes (n = 1). All examined subjects had stable OCT findings over the long follow-up period. Full-field ERGs showed evidence of a severe cone-rod dystrophy in 5 of 6 patients and undetectable ERGs in 1 subject. Novel genotype-phenotype correlations are also reported. GUCY2D-LCA is a severe early-onset retinal dystrophy associated with very poor VA from birth. Despite the severely affected photoreceptor function, the relatively preserved photoreceptor structure based on EZ integrity until late in the disease in the majority of subjects suggests a wide therapeutic window for gene therapy trials.

Identifiants

pubmed: 31704230
pii: S0002-9394(19)30515-X
doi: 10.1016/j.ajo.2019.10.019
pmc: PMC7013380
pii:
doi:

Substances chimiques

Receptors, Cell Surface 0
guanylate cyclase 1 0
Guanylate Cyclase EC 4.6.1.2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

59-70

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 099173/Z/12/Z
Pays : United Kingdom

Informations de copyright

Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.

Références

Arch Ophthalmol. 2000 Apr;118(4):538-43
pubmed: 10766140
Hum Gene Ther. 2012 Oct;23(10):1101-15
pubmed: 22845794
Hum Mol Genet. 2013 Jan 1;22(1):168-83
pubmed: 23035049
Ophthalmology. 2010 Jun;117(6):1190-8
pubmed: 20079931
Invest Ophthalmol Vis Sci. 2007 Sep;48(9):4284-90
pubmed: 17724218
Am J Ophthalmol. 2017 May;177:44-57
pubmed: 28212877
Hum Mutat. 2005 Feb;25(2):222
pubmed: 15643614
Biochem Biophys Res Commun. 2011 May 6;408(2):236-41
pubmed: 21463603
Invest Ophthalmol Vis Sci. 2006 Sep;47(9):3745-53
pubmed: 16936082
Hum Gene Ther. 2011 Oct;22(10):1179-90
pubmed: 21671801
Invest Ophthalmol Vis Sci. 2006 Mar;47(3):1167-76
pubmed: 16505055
Invest Ophthalmol Vis Sci. 2003 Aug;44(8):3544-50
pubmed: 12882805
Prog Retin Eye Res. 2018 Mar;63:69-91
pubmed: 29061346
Br J Ophthalmol. 2019 Jan 24;:
pubmed: 30679166
Eur J Hum Genet. 2000 Aug;8(8):578-82
pubmed: 10951519
Retina. 2018 Dec;38(12):2401-2414
pubmed: 29016458
BMC Med Genet. 2016 Jul 30;17(1):52
pubmed: 27475985
PLoS Med. 2006 Jun;3(6):e201
pubmed: 16700630
Graefes Arch Clin Exp Ophthalmol. 2016 Nov;254(11):2227-2238
pubmed: 27422788
Invest Ophthalmol Vis Sci. 2010 May;51(5):2608-14
pubmed: 19959640
Ophthalmic Genet. 2000 Sep;21(3):135-50
pubmed: 11035546
J Epidemiol Community Health. 2016 Aug;70(8):836-42
pubmed: 27095181
J Ophthalmol. 2015;2015:693468
pubmed: 26097748
Biochemistry. 1999 Jan 12;38(2):509-15
pubmed: 9888789
Doc Ophthalmol. 2015 Feb;130(1):1-12
pubmed: 25502644
PLoS One. 2015 Jul 06;10(7):e0131679
pubmed: 26147992
Br J Ophthalmol. 2017 Sep;101(9):1147-1154
pubmed: 28689169
Invest Ophthalmol Vis Sci. 2001 May;42(6):1190-2
pubmed: 11328726
Am J Ophthalmol. 2007 Dec;144(6):791-811
pubmed: 17964524
J R Soc Med. 2006 Apr;99(4):189-91
pubmed: 16574971
Am J Ophthalmol. 2008 Apr;145(4):687-94
pubmed: 18242574
Am J Ophthalmol. 2018 Jun;190:58-68
pubmed: 29559409
Doc Ophthalmol. 2013 Feb;126(1):1-7
pubmed: 23073702
Br J Ophthalmol. 2018 Aug;102(8):1028-1035
pubmed: 29141905
J AAPOS. 2009 Dec;13(6):587-92
pubmed: 20006823
Invest Ophthalmol Vis Sci. 2017 Feb 1;58(2):959-973
pubmed: 28403437

Auteurs

Zaina Bouzia (Z)

Moorfields Eye Hospital, London, United Kingdom; UCL Institute of Ophthalmology, University College London, London, United Kingdom.

Michalis Georgiou (M)

Moorfields Eye Hospital, London, United Kingdom; UCL Institute of Ophthalmology, University College London, London, United Kingdom.

Sarah Hull (S)

Moorfields Eye Hospital, London, United Kingdom; UCL Institute of Ophthalmology, University College London, London, United Kingdom.

Anthony G Robson (AG)

Moorfields Eye Hospital, London, United Kingdom; UCL Institute of Ophthalmology, University College London, London, United Kingdom.

Kaoru Fujinami (K)

Moorfields Eye Hospital, London, United Kingdom; UCL Institute of Ophthalmology, University College London, London, United Kingdom; Laboratory of Visual Physiology, Division of Vision Research, National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Center, Tokyo, Japan; Department of Ophthalmology, Keio University School of Medicine, Tokyo, Japan.

Tryfon Rotsos (T)

First Division of Ophthalmology, National and Kapodistrian University of Athens, General Hospital of Athens, Athens, Greece.

Nikolas Pontikos (N)

Moorfields Eye Hospital, London, United Kingdom; UCL Institute of Ophthalmology, University College London, London, United Kingdom.

Gavin Arno (G)

Moorfields Eye Hospital, London, United Kingdom; UCL Institute of Ophthalmology, University College London, London, United Kingdom.

Andrew R Webster (AR)

Moorfields Eye Hospital, London, United Kingdom; UCL Institute of Ophthalmology, University College London, London, United Kingdom; UK Inherited Retinal Dystrophy Consortium, United Kingdom.

Alison J Hardcastle (AJ)

UCL Institute of Ophthalmology, University College London, London, United Kingdom; UK Inherited Retinal Dystrophy Consortium, United Kingdom.

Alessia Fiorentino (A)

UCL Institute of Ophthalmology, University College London, London, United Kingdom; UK Inherited Retinal Dystrophy Consortium, United Kingdom.

Michel Michaelides (M)

Moorfields Eye Hospital, London, United Kingdom; UCL Institute of Ophthalmology, University College London, London, United Kingdom; UK Inherited Retinal Dystrophy Consortium, United Kingdom. Electronic address: michel.michaelides@ucl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH